Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Thymosin-alpha-1

Thymalfasin, Zadaxin, Thymosin α1

Quick Stats
Studies 759
Trials 63
Score 1
1983 pubmed 1 citations

Immunological studies of male homosexuals with the prodrome of the acquired immunodeficiency syndrome (AIDS).

Hersh. E M EM; Reuben. J M JM; Mansell. P W PW; Rios. A A; Newell. G R GR; Frank. J J; Goldstein. A L AL

Key Findings

  • Low helper T‑cell counts and inverted helper:suppressor ratio
  • Elevated serum thymosin‑alpha‑1 levels in early AIDS patients
  • Normal NK cell activity and ADCC despite other immune deficits

Practical Outcomes

  • For biohackers, this paper doesn’t provide a protocol or dosage for thymosin‑alpha‑1. The high natural levels seem to be a disease response, not a proven benefit, so using the peptide for longevity or performance isn’t supported by this data.

Summary

The study measured immune markers in men with early signs of AIDS and found they had low helper T‑cells, an inverted helper‑to‑suppressor ratio, low monocytes, but surprisingly high levels of the peptide thymosin‑alpha‑1 in their blood. No thymosin‑alpha‑1 was given, and the paper only suggests testing immune‑boosting drugs, not how to use the peptide for health.

Abstract

Homosexual patients who mainly had the prodrome of the syndrome of opportunistic infection and Kaposi's sarcoma were studied immunologically. Patients showed diminished delayed hypersensitivity to recall antigens, diminished lymphocyte blastogenic responses, a suppressor cell for lymphocyte proliferative responses, low helper cells and an inverted helper:suppressor ratio. The patients had low levels of adherent monocytes. NK cell activity and antibody dependent cellular cytotoxicity were normal. Virtually all patients showed elevated serum thymosin alpha 1 levels and elevated serum lysozyme levels. The most consistent findings were the low helper cells, inverted helper:suppressor ratio and elevated serum thymosin alpha 1 and lysozyme. The patients with the prodrome should be subjected to therapeutic research with immunorestorative drugs.

Study Information

Provider

pubmed

Year

1983

Date

1983-12-01T00:00:00.000Z

DOI

10.1007/978-1-4757-1410-4_24

Citations

1

References

14